December 18, 2009 - The U.S. radiopharmacy network currently owned by Covidien is being sold to Triad Isotopes in a deal announced today. Covidien said it decided to divest its network of 37 Mallinckrodt radiopharmacies after evaluating the radiotracer market. The company said it wants to streamline its portfolio and concentrate resources in its faster-growing, higher-margin businesses.

December 16, 2009 - Many healthcare providers who are pursuing meaningful use objectives and meeting with deadlines defined within the HITECH provision of the American Recovery and Reinvestment Act (ARRA) are challenged with securing the capital investment needed to meet the aggressive schedules.

December 16, 2009 – The FDA's Endocrinologic and Metabolic Drugs Advisory Committee yesterday agreed AstraZeneca established sufficient benefit with trial data showing prophylactic benefit of prescribing CRESTOR (rosuvastatin calcium) to healthy individuals to prevent heart disease.

December 15, 2009 – The Department of Defense (DoD) awarded a contract to Philips Healthcare for its HeartStart MRx monitor/defibrillator, which has the potential of generating more than $29 million for the company.

December 15, 2009 - The European Medicines Agency (EMEA) recently approved a new indication for Procoralan (ivabradine) for chronic, stable angina patients, who remain inadequately controlled despite an optimal dose of beta blockers, and whose heart rate is above 60 beats per minute.

December, 14, 2009 – A supplemental new drug application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR, a cholesterol medication.

December 14, 2009 – For its unique Return to Work Lab, which focuses on individualized rehabilitation for younger, more active cardiac patients, the Baylor Jack and Jane Hamilton Heart and Vascular Hospital in north Texas recently received an award.